Related Documents
-
Notice: Human drugs:
New drug applications— Penthrane (methoxyflurane) Inhalation Liquid, 99.9 percent; approval withdrawn
94 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— TEQUIN injection, 10 milligrams
64 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— PHENERGAN (Promethazine hydrochloride) tablets, 12.5 milligrams and 50 milligrams
84 reads -
Notice: Harmonisation International Conference; guidelines availability: ZYVOX (linezolid) tablets, 400 milligrams
70 reads -
Notice: Harmonisation International Conference; guidelines availability: Biotechnological/biological products; Q5E comparability subject to changes in manufacturing process
70 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— ACIPHEX (rabeprazol sodium)
64 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
48 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Animal Drug User Fee Act; performance and reauthorization
34 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
14 reads -
Notice: Privacy Act; computer matching programs
15 reads -
Notice: Human drugs:
New drug applications— Premarket approval applications; list; safety and effectiveness summaries’ availability
105 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
38 reads -
Notice: Human drugs:
Best Pharmaceuticals for Children Act— Pediatric studies; INVANZ , KEPPRA, TRILEPTAL, and ZYVOX; medical and clinical pharmacology review summaries; availability
239 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— DECADRON tablets
104 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— SURPASS
42 reads -
Notice: Withdrawn
27 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
37 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— PEPTAVLON (Pentagastrin) for subcutaneous injection, 0.25 milligrams per milliliter
131 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
26 reads
Related Documents
Flag this document
2 Pages
